Pregabalin + MethylcobalaminThird Party Manufacturing in India

Pregabalin and Methylcobalamin combine two complementary mechanisms for the management of neuropathic pain. Pregabalin works by binding to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system. This binding reduces depolarization-induced calcium influx into nerve terminals, decreasing the release of excitatory neurotransmitters such as glutamate, noradrenaline, and substance P that drive neuropathic pain signaling. Methylcobalamin, the active form of vitamin B12, provides neuronal protection and repair mechanisms. It promotes myelination and regeneration of injured peripheral nerves by stimulating the synthesis of axonal proteins and supporting Schwann cell function. Methylcobalamin improves nerve conduction velocity and inhibits ectopic spontaneous discharges from injured sensory neurons that contribute to neuropathic pain. It also exhibits anti-inflammatory effects by regulating NF-κB activity, reducing pro-inflammatory cytokines, and rebalancing the inflammatory response in damaged nerve tissue. The combination offers a dual approach: pregabalin provides rapid symptomatic relief by modulating pain signaling, while methylcobalamin addresses the underlying nerve damage through neurotrophic and regenerative mechanisms. This synergistic action makes the combination particularly effective for peripheral neuropathy associated with diabetes, postherpetic neuralgia, and other chronic neuropathic conditions.

Therapeutic Uses

Pregabalin + Methylcobalamin is prescribed for the treatment of:

• Diabetic Peripheral Neuropathy: The combination addresses both the neuropathic pain and the underlying nerve damage associated with long-standing diabetes, providing symptomatic relief alongside neuroregenerative benefits.
• Postherpetic Neuralgia: Persistent nerve pain following shingles infection responds well to the dual mechanism of gabapentinoid pain modulation and vitamin B12-mediated nerve repair.
• Trigeminal Neuralgia: This combination offers a safer alternative to carbamazepine for patients requiring long-term management of facial nerve pain.
• Chemotherapy-Induced Peripheral Neuropathy: Methylcobalamin's neuroprotective properties help mitigate chemotherapy-related nerve damage while pregabalin controls the associated pain.
• Cervical and Lumbar Radiculopathy: Nerve root compression with radiating pain benefits from the combination's analgesic and neuroregenerative effects.
• HIV-Associated Neuropathy: The combination provides symptomatic relief and may slow progression of HIV-related peripheral nerve damage.

Why Manufacturers Choose Pregabalin + Methylcobalamin

This combination is one of the fastest-growing segments in the Indian neuropathic pain market. The pregabalin plus methylcobalamin fixed-dose combination has become a physician-preferred choice for diabetic neuropathy and other chronic pain conditions, with multiple strengths (75mg+750mcg and 75mg+1500mcg) available to meet varying clinical needs. Indian manufacturers find this combination attractive due to high prescription volumes, strong brand loyalty, and the opportunity to offer differentiated products in a competitive market. The combination allows for premium positioning versus pregabalin monotherapy, offering better margins while addressing a large and growing patient population affected by diabetes and age-related neuropathy. WHO-GMP certified manufacturers with advanced tablet coating capabilities can produce high-quality combination tablets that meet both domestic and export regulatory standards.

This makes Pregabalin + Methylcobalamin one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.